The Tough Tech problem we are solving
Precision Diagnostics Without Compromise
Healthcare's most persistent challenge isn't just developing accurate diagnostic tests—it's making them accessible and affordable without sacrificing reliability. Today's diagnostic landscape forces an impossible choice: either invest in expensive, high-precision equipment that only well-funded facilities can afford or settle for lower-cost alternatives that compromise on accuracy and specificity.
This creates a dangerous healthcare equity gap. Critical diagnostic capabilities remain locked behind institutional walls, limiting access for underserved populations, remote communities, and resource-constrained healthcare providers. Meanwhile, attempts to democratize diagnostics through cost reduction often result in false positives, missed diagnoses, and diminished clinical confidence.
About our solution
Our Breakthrough Approach
Hyperion Biosystems has created a suite of diagnostic devices and techniques spanning traditional antigen tests and syndromic molecular panels that deliver exquisite performance at the lowest price. We've cracked the fundamental trade-off of cost and reliability through our pioneering fusion of advanced AI, machine vision, and physics-based algorithms. Rather than accepting the limitations of lower-cost hardware, we amplify its capabilities to match - and often exceed - the performance of premium diagnostic systems.
Our proprietary technology doesn't just process data; it intelligently identifies false positives, delineates non-specific binding, and mitigates assay defects in real-time. This enables us to deliver 10x average sensitivity enhancement using low-cost hardware platforms, without requiring expensive infrastructure overhauls.